< Back to latest news & events

News

EPO sets start of Unitary Patent transitional measures as 1 January 2023

November 2022

The EPO has announced that it intends to adjust the start date of its transitional measures for Unitary Patents (UP) to 1 January 2023.

From that date, applicants who have received a 71(3) letter (EPO intention to grant) may file early requests for unitary effect and requests for a delay in issuing the decision to grant a European patent (to allow for a UP request). The measures are applicable until the entry into operation of the UP system and UPC which is expected to be on 1 April 2023.

The two transitional measures are interrelated but separate from a procedural perspective. Prior to this announcement, both measures were also dependent on the deposit of Germany’s ratification of the UPC Agreement.

The EPO’s dedicated webpage has been updated, and in brief, the transitional measures are as follows:

1. Early request for unitary effect

The first transitional measure enables applicants to file early requests for unitary effect before the start of the UP system. This will allow the EPO to register unitary effect immediately at the start of the Unified Patent Court (UPC) system, provided all corresponding requirements are met. The EPO will allow early requests for unitary effect as of 1 January 2023.

Early requests for unitary effect may only be filed for European patent applications in respect of which a communication under Rule 71(3) EPC has been despatched. Where an early request for unitary effect is filed before the 1 January 2023 and/or if a Rule 71(3) EPC-communication has not been despatched, it will not be treated as a request for unitary effect. The applicant will be invited to resubmit their request once both conditions are met.

2. Request for a delay in issuing the decisions to grant a European patent

The second transitional measure will provide the possibility for the applicant to request a delay in issuing the decision to grant a European patent after despatch of a communication under Rule 71(3) EPC and before approving the text intended for grant. This will make a European patent eligible for Unitary Patent protection that would otherwise have been granted before the start of the UPC, and will avoid applicants missing the opportunity to obtain a UP in the transitional phase.

The EPO will allow requests for a delay in issuing the grant as of 1 January 2023. Moreover, a request for delay may be validly filed only for European patent applications in respect of which the applicant has been informed of the text intended for grant by a communication under Rule 71(3) EPC but has not yet approved that text. A request for delay filed on the same day as the approval of the text intended for grant will be considered to have been validly filed. The request for delay must be filed using a dedicated request form provided by the EPO. A request not meeting the requirements will be deemed not to have been filed.

Latest updates

Exam Success!

HGF are delighted to announce success for many of our colleagues in the recent exams on becoming qualified attorneys and would like to congratulate them on this fantastic achievement. Martyn …

Read article

In2ScienceUK continues to promote diversity and inclusion in STEM and IP with its award winning programme

HGF are proud sponsors of In2ScienceUK, a charity that gives young people from low-income backgrounds the opportunity to gain essential insights into science, technology, engineering, and mathematics (STEM) careers with …

Read article

Spotting innovation in digital health – and can you patent it?

Intellectual Property (IP) can add significant value to your business, providing a competitive edge over the market, as well as demonstrating sound business planning to help secure investment. There are …

Read article

Innovation at the heart of UK medtech strategy

The UK Department of Health and Social Care has recently published the government’s first ever medical technology strategy in an effort to accelerate access to innovative technologies. The strategy document …

Read article

How medtech start-ups can supercharge their IP for fundraising

Why is IP important for fundraising? Intellectual property (IP) rights underpin the value of most medtech start-up companies. IP rights include patents, design rights, trade marks, copyright and trade secrets …

Read article

What is EUDAMED and how will it affect your IP strategy?

The “European database on medical devices”, or “EUDAMED”, is the EU’s IT system created by the new Medical Devices Regulation (MDR) and In Vitro Diagnostics Medical Devices Regulation (IVDR). When …

Read article